Looking to evaluate a verified domestic supplier for research-grade Chonluten targeted at TNF inhibition and inflammatory cytokine signaling assays? PX1 Research provides analytical-grade tripeptide reagents manufactured in the United States, complete with independent lot-specific certificates of analysis.
Looking to evaluate a verified domestic supplier for research-grade Chonluten targeted at TNF inhibition and inflammatory cytokine signaling assays? PX1 Research provides analytical-grade tripeptide reagents manufactured in the United States, complete with independent lot-specific certificates of analysis.
When evaluating options to buy peptide TNF inhibition Chonluten supplier materials, laboratory researchers require fully documented chemical identity, verified high purity, and stringent endotoxin controls. Chonluten is a synthetic tripeptide (L-Glu-L-Asp-L-Gly) investigated in preclinical models for its capacity to modulate inflammatory cytokine cascades, particularly tumor necrosis factor-alpha (TNF-α) production and downstream cellular responses.
PX1 Research serves as a trusted domestic supplier, delivering USA-manufactured Chonluten specifically synthesized for *in vitro* assays and animal tissue models. Every lot undergoes rigorous third-party testing via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to guarantee chemical identity and purity standards exceeding 98%. Browse our complete selection of research peptides to support your laboratory's ongoing mechanistic investigations.
Chonluten is a short-chain bioregulatory peptide comprised of three amino acid residues: L-glutamic acid, L-aspartic acid, and glycine (sequence: Glu-Asp-Gly or E-D-G). With a molecular weight of approximately 305.24 g/mol, its simple tripeptide framework allows it to interact directly with cellular chromatin and specific nuclear protein complexes in target tissues.
Because of its low molecular weight, Chonluten easily diffuses across biological membranes in tissue cultures and cellular assays. When sourcing this reagent, researchers must ensure that the synthesized product maintains correct stereochemistry and structural integrity. Unmodified Chonluten tripeptide supplied by PX1 Research is lyophilized into a stable trifluoroacetate (TFA) salt or acetate formulation, optimized for precise reconstitution in standard laboratory buffers.
Tumor Necrosis Factor-alpha (TNF-α) is a primary pro-inflammatory cytokine produced chiefly by activated macrophages and monocytes. In pathology models, elevated TNF-α concentrations drive nuclear factor kappa B (NF-κB) nuclear translocation, inducing expression of downstream inflammatory mediators such as IL-1β, IL-6, and inducible nitric oxide synthase (iNOS).
Preclinical studies suggest that Chonluten operates through direct and indirect genomic mechanisms. *In vitro* data indicate that the tripeptide binds to specific histone proteins and DNA promoter regions within bronchial mucosal cells and immune populations. By modulating gene expression, Chonluten has been observed to attenuate hyper-reactive TNF-α expression under oxidative or toxic stress conditions. Researchers investigating chronic inflammatory states utilize this compound to explore how short-chain peptides restore homeostatic cytokine balances without causing complete systemic immune suppression.
The primary body of literature regarding Chonluten focuses on respiratory biology, lung tissue injury models, and epithelial barrier function. In rodent models subjected to acute lung injury (ALI) or toxic inhalant exposure, administration of Chonluten resulted in measurable reductions in bronchoalveolar lavage fluid (BALF) levels of TNF-α, IL-6, and myeloperoxidase (MPO) activity.
Furthermore, tissue histology from animal studies demonstrated reduced neutrophil infiltration and preserved alveolar capillary membrane integrity following peptide treatment. Observations in organotypic cell cultures derived from bronchial epithelium indicate that Chonluten promotes protein synthesis associated with cell survival and structural repair. Investigators can access detailed data sets and related findings through our research library hub to inform prospective experimental designs.
In cytokine modulation and tissue repair research, several peptide compounds are evaluated alongside Chonluten. Understanding their distinct mechanisms, target receptors, and primary pathways is critical when selecting reagents for comparative assay panels.
While Chonluten focuses primarily on respiratory mucosa and TNF-α signaling via epigenetic chromatin interactions, related short-chain bioregulators like Bronchogen target overlapping bronchial transcription factors. In contrast, systemic repair peptides such as BPC-157 act largely via VEGFR2 phosphorylation and focal adhesion kinase pathways to promote angiogenesis and gastrointestinal healing. For direct anti-inflammatory receptor signaling, the tripeptide KPV acts as an alpha-MSH derivative that directly inhibits NF-κB activation across diverse epithelial surfaces. Combining or contrasting these agents in *in vitro* protocols provides comprehensive insights into distinct inflammatory control mechanisms.
When purchasing Chonluten for TNF inhibition research, selecting a reliable supplier requires evaluating stringent quality control parameters. Impurities, synthesis side-products, or leftover reagents from solid-phase peptide synthesis (SPPS) can induce non-specific cellular responses, compromising assay validity.
PX1 Research enforces rigorous quality assurance standards for every production lot:
• **Reverse-Phase HPLC (RP-HPLC):** Verifies physical purity exceeding 98%, ensuring the absence of truncated or deletion sequences.
• **Electrospray Ionization Mass Spectrometry (ESI-MS):** Confirms exact molecular weight (monoisotopic mass) and structural identity.
• **Limulus Amebocyte Lysate (LAL) Endotoxin Testing:** Ensures bacterial endotoxin levels remain below 0.05 EU/mg. Endotoxin contamination is a major confounder in TNF-α research because lipopolysaccharides (LPS) artificially trigger massive TNF-α release.
• **Lot Traceability:** Every vial is linked to a downloadable, lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited laboratory.
Proper handling and storage of lyophilized peptides are essential for maintaining molecular stability over extended experimental timelines. Chonluten should be preserved in its dry state at -20°C or -80°C in a desiccated environment away from light.
For *in vitro* reconstitution, researchers should utilize sterile, endotoxin-free Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4). Avoid rapid vortexing; instead, gently swirl the vial until the cake is fully dissolved. Stock solutions intended for multi-day cell culture protocols should be aliquoted into single-use polypropylene microtubes and stored at -80°C to minimize freeze-thaw cycles, which degrade peptide bonds over time.
Securing a dependable supply chain is critical for long-term preclinical studies. Foreign peptide brokers often lack lot-to-lot consistency, domestic quality oversight, or transparent endotoxin reporting. PX1 Research operates fully within the United States, utilizing cGMP-compliant manufacturing processes to produce high-grade research compounds.
We ship directly from our facilities in California and Arizona with same-day dispatch for orders placed before cutoff times. For academic departments, contract research organizations (CROs), and industrial laboratories requiring larger quantities or ongoing supply agreements, explore our wholesale lab account portal to access volume pricing and custom synthesis options.
What is Chonluten studied for in preclinical research?
Chonluten is studied primarily for its potential to modulate inflammatory cytokine expression (specifically TNF-α, IL-1β, and IL-6) and promote bronchial and pulmonary epithelial repair in *in vitro* and animal models.
How does Chonluten influence TNF-alpha pathways in cell models?
Preclinical data indicate Chonluten interacts with nuclear chromatin structures to alter gene transcription, leading to reduced downstream NF-κB signaling and suppressed TNF-α overproduction during toxic or oxidative cellular stress.
Why is endotoxin testing critical when buying Chonluten for TNF inhibition research?
Endotoxins (LPS) potently stimulate TNF-α release in cell cultures. If a peptide sample contains trace endotoxins, it will cause false-positive TNF-α spikes, invalidating any research assessing TNF inhibition. PX1 Research tests every batch to ensure endotoxin levels remain below 0.05 EU/mg.
What analytical documentation comes with PX1 Research Chonluten?
Every lot of Chonluten includes an independent, third-party Certificate of Analysis (COA) detailing RP-HPLC purity, mass spectrometry mass confirmation, and LAL endotoxin test results.
How should lyophilized Chonluten be stored upon arrival?
Lyophilized Chonluten should be stored at -20°C to -80°C upon receipt. Reconstituted stock solutions should be divided into single-use aliquots and kept at -80°C to avoid repeated freeze-thaw degradation.
What solvents are recommended for reconstituting Chonluten in lab settings?
Sterile endotoxin-free water or sterile phosphate-buffered saline (PBS, pH 7.4) are standard reconstitution vehicles for Chonluten in cellular and tissue culture assays.
Are PX1 Research compounds intended for human clinical use?
No. All products sold by PX1 Research are strict research compounds intended exclusively for *in vitro*, cellular, and non-human animal laboratory experimentation. They are not for human or veterinary medical use.
Where does PX1 Research manufacture and ship its peptides from?
PX1 Research manufactures its peptides in state-of-the-art cGMP-compliant facilities in the USA and ships directly from warehouses in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.